Strategic adoption of model-informed drug development (MIDD) as an overarching business model in biotechnology and life science industry

Drug Discovery Today 2026

View at publisher

Authors: Rajesh Krishna

DOI: 10.1016/j.drudis.2026.104668

Cited by: 3

References: 10

Fields of Study & Subjects

Statistical Methods in Clinical Trials Health Systems Economic Evaluations Quality of Life Advanced Causal Inference Techniques

References 10